how many people are on glp 1 drugs GLP-1 Market Size to Hit USD 132.79 Bn by 2035 The popularity of GLP-1 drugs

They are also increasingly finding that these drugs may help reduce inflammation, a hallmark of cancer

Beinaglutide showed significant weight-loss benefit and effective glycaemic control for the treatment of type 2 diabetes in a real-world setting: a 3-month, multicentre, observational, retrospective, open-label study

But as more patients explore or discontinue these medications, functional and integrative medicine providers have a growing opportunity to offer complementary or alternative strategies that support similar metabolic pathwaysoften with fewer side effects

Microbiol 80 , 29912997 (2014)

65% of patients achieved more than 10% weight loss compared to 0% placebo

Moreover, IBD patients exhibited lower prevalence of nausea, vomiting, and diarrhea, but increased rates of constipation (11%) in comparison to the general population (103)